Description
Seeking men and women 18 years of age or older with relapsing multiple sclerosis (RMS) for participation in a study comparing an investigational drug called fenebrutinib to a drug called teriflunomidie.
Overview
We are studying the effects of an investigational drug fenebrutinib and its safety for patients with RMS in comparison to teriflunomide.
What we're hoping for
To determine whether the effects of fenebrutinib versus teriflunomide provide benefits to patients with RMS
Additional Information
ClinicalTrials.gov Identifier: NCT04544449